Literature DB >> 25395468

Steroid-induced scleroderma renal crisis in an at-risk patient.

Sebastian Miguel Toescu1, Alex Mansell1, Eoin Dinneen2, Malcolm Persey3.   

Abstract

Scleroderma renal crisis (SRC) is a major complication of systemic sclerosis (SSc). We present a case of a patient who died of complications attributable to SRC in the context of recently diagnosed SSc. We review the typical clinical and laboratory features of SSc present in our patient and highlight those that identify greater risk of progression to SRC. Particular risk factors for SRC include cutaneous involvement, positive anti-RNA polymerase III antibodies and use of corticosteroids (CS). The authors emphasise the importance of risk evaluation when choosing to use CS in patients with SSc. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25395468      PMCID: PMC4244392          DOI: 10.1136/bcr-2014-206675

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  A cohort study of cancer incidence in systemic sclerosis.

Authors:  Chris T Derk; Mehmoodur Rasheed; Carol M Artlett; Sergio A Jimenez
Journal:  J Rheumatol       Date:  2006-03-15       Impact factor: 4.666

2.  Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.

Authors:  Loïc Guillevin; Alice Bérezné; Raphaèle Seror; Luis Teixeira; Jacques Pourrat; Alfred Mahr; Eric Hachulla; Christian Agard; Jean Cabane; Philippe Vanhille; Jean-Robert Harle; Isabelle Deleveaux; Luc Mouthon
Journal:  Rheumatology (Oxford)       Date:  2011-11-15       Impact factor: 7.580

Review 3.  Epidemiology of systemic sclerosis.

Authors:  Mandana Nikpour; Wendy M Stevens; Ariane L Herrick; Susanna M Proudman
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-12       Impact factor: 4.098

4.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

5.  Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.

Authors:  Ahmed Alayoud; Ouadie Qamouss; Amine Hamzi; Mohammed Benyahia; Zouhir Oualim
Journal:  Arab J Nephrol Transplant       Date:  2012-09

Review 6.  Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review.

Authors:  Michele Iudici; Marlies C van der Goes; Gabriele Valentini; Johannes W J Bijlsma
Journal:  Clin Exp Rheumatol       Date:  2013-07-23       Impact factor: 4.473

Review 7.  Renal complications and scleroderma renal crisis.

Authors:  C P Denton; G Lapadula; L Mouthon; U Müller-Ladner
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

Review 8.  Scleroderma--clinical and pathological advances.

Authors:  Christopher P Denton; Carol M Black
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-06       Impact factor: 4.098

9.  Scleroderma renal crisis: patient characteristics and long-term outcomes.

Authors:  H Penn; A J Howie; E J Kingdon; C C Bunn; R J Stratton; C M Black; A Burns; C P Denton
Journal:  QJM       Date:  2007-06-29

10.  Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

Authors:  Mandana Nikpour; Pravin Hissaria; Jillian Byron; Joanne Sahhar; Maree Micallef; William Paspaliaris; Janet Roddy; Peter Nash; Alan Sturgess; Susanna Proudman; Wendy Stevens
Journal:  Arthritis Res Ther       Date:  2011-12-22       Impact factor: 5.156

View more
  1 in total

Review 1.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.